Skip to main content
Fig. 3 | Journal of Medical Case Reports

Fig. 3

From: Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports

Fig. 3

Flow cytometry of peripheral blood mononuclear cells (PBMCs) before and 2 weeks after combination therapy with ICI and ACT. The phenotype of PBMCs was analyzed as described in “Patients and methods.” The phenotype and mean ± standard deviation (shaded box) in healthy subjects are shown in each graph. The solid line indicates the number of cells in case 1, and the dotted line indicates that in case 2

Back to article page